Massachusetts Eye and Ear Infirmary v. QLT, INC.
District Court, D. Massachusetts
1Opinion of the Court
MEMORANDUM AND ORDER
YOUNG, District Judge.
I. INTRODUCTION
This lawsuit is the result of failed business negotiations for a royalty on the net sales of Visudyne, a blockbuster drug prescribed to treat age-related macular de generation. In the early to mid-1990s, researchers at Massachusetts Eye and Ear Infirmary (“MEEI”) demonstrated that the drug had promise in treating age-related macular degeneration, a leading cause of blindness. QLT, Inc. (“QLT”) owns the compositional patent to the drug. QLT promised MEEI that it would negotiate for the licensing rights to the medical procedure. After the…
2Cases cited55 opinions
- Beacon Theatres, Inc. v. WestoverSupreme Court of the United States · 1959
- Dairy Queen, Inc. v. WoodSupreme Court of the United States · 1962
- Curtis v. LoetherSupreme Court of the United States · 1974
- Tull v. United StatesSupreme Court of the United States · 1987
- Chauffeurs, Teamsters & Helpers Local No. 391 v. TerrySupreme Court of the United States · 1990
50 more not listed; retrieve them via the Exa API.
3Cited by10 opinions
- Massachusetts Eye & Ear Infirmary v. QLT Phototherapeutics, Inc.Court of Appeals for the First Circuit · 2009
- Full Spectrum Software, Inc. v. Forte Automation Systems, Inc.Court of Appeals for the First Circuit · 2017
- In re TJX Companies Retail Security Breach LitigationDistrict Court, D. Massachusetts · 2007
- Hi-Tech Pharmaceuticals, Inc. v. CohenDistrict Court, D. Massachusetts · 2016
- Bryksa v. B & B Protector Plans, Inc.District Court, D. Massachusetts · 2010
5 more not listed; retrieve them via the Exa API.